Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,788.50
Bid: 1,788.50
Ask: 1,789.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 22nd Apr 2013 07:20

Admiral Group: Deutsche Bank takes target price from 1140p to 1300p retaining a hold recommendation.African Barrick Gold: Deutsche Bank ups target price from 173p to 180p staying with its hold recommendation.Albemarle & Bond: Canaccord Genuity reduces target price from 280p to 146p and downgrades from a speculative buy to hold.Anglo American: Deutsche Bank cuts target price from 2210p to 2170p, while its buy recommendation remains unaltered. HSBC Holdings moves target price from 2240p to 2250p and maintains an overweight rating.Antofagasta: HSBC Holdings moves target price from 1160p to 1080p and reiterates a neutral rating.AstraZeneca: Credit Suisse increases target price from 3050p to 3130p and maintains an underperform rating.BHP Billiton: HSBC Holdings reduces target price from 2250p to 2110p, while upgrading to overweight. Espirito Santo cuts target price from 1703p to 1605p, while upgrading to neutral.Brooks Macdonald: Canaccord Genuity revises target price from 1540p to 1620p keeping a buy recommendation.Brown (N) Group: HSBC Holdings takes target price from 430p to 485p and retains an overweight rating.Burford Capital: Espirito Santo revises target price from 149p to 140p and stays with its buy recommendation.Cable & Wireless Communications: Jefferies shifts target price from 40p to 42p and retains a hold recommendation.Chariot Oil & Gas: UBS cuts target price from 70p to 20p downgrading from buy to neutral.Electrocomponents: Goldman Sachs reduces target price from 311p to 277p and downgrades to neutral.Eurasian Natural Resources: Exane BNP raises target price from 270p to 320p staying with a neutral rating.GlaxoSmithKline: Credit Suisse increases target price from 1450p to 1670p and reiterates its neutral rating.Hansteen Holdings: Espirito Santo lowers target price from 76p to 85p maintaining a neutral rating.Ithaca Energy: Westhouse Securities ups target price from 165p to 200p and reiterates a buy recommendation. RBC Capital increases target price to 225p and keeps an outperform rating.Kazakhmys: Credit Suisse upgrades from underperform to neutral with its target price at 450p. Exane BNP increases target price from 350p to 390 upgrading to neutral.Legal & General Group: Deutsche Bank ups target price from 170p to 189p keeping a buy recommendation.Lloyds Banking Group: RBC Capital shifts target price from 69p to 65p and reiterates an outperform rating.NetDimensions: Sanlam Securities restarts with a target price of 80p and a buy recommendation.New World Resources: Exane BNP cuts target price from 180p to 165p and leaves its underperform rating unchanged.Premier Farnell: Goldman Sachs lowers target price from 240p to 226p and downgrades to neutral.Prudential: Deutsche Bank increases target price from 1060p to 1240p maintaining its buy recommendation.Reckitt Benckiser: Canaccord Genuity takes target price from 3425p to 4100p, but still recommends selling.Regus: JP Morgan shifts target price from 135p to 140p, while downgrading to underweight.Rentokil Initial: Deutsche Bank moves target price from 76p to 100p reiterating a hold recommendation.Resolution: Deutsche Bank lowers target price from 285p to 273p and keeps a hold recommendation.Rio Tinto: HSBC Holdings cuts target price from 4180p to 4160p, while its overweight rating remains unchanged. Espirito Santo raises target price from 2910p to 3160p and upgrades to neutral.Sagentia Group:Westhouse Securities downgrades from add to neutral with a target price of 107p.Segro: Espirito Santo shifts target price from 247p to 250p and leaves its neutral rating unchanged.Spectris: Goldman Sachs cuts target price from 3250p to 2850p maintaining a strong buy recommendation. Credit Suisse reduces target price from 2670p to 2350p and retains an outperform rating. UBS takes target price from 2700p to 2500p, while leaving its buy recommendation unchanged. Bank of America moves target price from 2080p to 1980p and keeps an underperform rating. JP Morgan reduces target price from 2575p to 2455p, while its overweight rating remains unchanged.Spirent Communications: Jefferies reduces target price from 196p to 140p keeping a buy recommendation. Investec places its target price (prev. 175p) under review reiterating its buy recommendation. Canaccord Genuity lowers target price from 135p to 120p and retains a hold recommendation.St James's Place: Deutsche Bank raises target price from 485p to 525p, while keeping a hold recommendation.Sweett Group: WH Ireland shifts target price from 27p to 33p and moves from a speculative buy to a buy rating.Talk Talk Telecom: Jefferies moves target price from 270p to 284p and maintains a buy recommendation. Credit Suisse raises target price from 200p to 275p and retains an outperform rating.Travis Perkins: Goldman Sachs downgrades from strong buy to buy with a target price of 1708p.Vedanta Resources: HSBC Holdings reduces target price from 1310p to 1280p and maintains its neutral rating.Vodafone Group: Jefferies shifts target price from 174p to 179p keeping a hold recommendation.Whitbread: Credit Suisse increases target price from 2760p to 2900p reiterating an outperform rating.William Hill: Nomura shifts target price from 333p to 339p and stays with its reduces rating. JP Morgan moves target price from 485p to 490p keeping an overweight rating.
More News
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.